retatrutide trials weight loss Blog – Maryland Trim Clinic Retatrutide: A Triple Agonist Shaping
Description
1, Table 1)
By targeting GLP-1 + GIP + Glucagon receptors, clinical studies have reported weight loss approaching 24% or more, making it one of the most effective obesity therapies under development
Users losing 80+ pounds over the treatment course should prepare for some degree of skin laxity and may benefit from skin tightening treatments post-weight loss
Her doctor then recommended a GLP-1 drug, but getting insurance coverage was a challenge, requiring an extensive pre-authorization process and two appeals
